Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparing mini-crush and controlled balloon-crush techniques for treating coronary bifurcation lesions

Official title: Mini-Crush Or Controlled Balloon-Crush For True Coronary Bifurcation Lesions

Run by Istanbul Mehmet Akif Ersoy Educational and Training Hospital · NCT06880978 · Data updated 2026-11-12

This study is testing whether two different stenting techniques, mini-crush and controlled balloon-crush, work better for treating complex heart artery blockages in people with coronary bifurcation lesions.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorIstanbul Mehmet Akif Ersoy Educational and Training Hospital
Government
Locations1 site (Istanbul)
StatusRecruiting
StartedMarch 3, 2025
Main results expectedAugust 1, 2025
Study endsAugust 1, 2026
Registry record updatedMarch 18, 2025
Trial IDNCT06880978 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with complex coronary bifurcation lesions suitable for PCI using mini-crush or controlled balloon-crush techniques.

Probably not a fit

Patients with non-complex bifurcation anatomy or those with severe comorbidities such as end-stage liver or kidney disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the effectiveness of two stenting techniques, mini-crush and controlled balloon-crush, in treating complex coronary bifurcation lesions. The mini-crush technique has been widely used by interventional cardiologists, but challenges remain in its execution, particularly in rewiring and balloon advancement. The study aims to compare clinical outcomes between these two techniques to determine if one offers significant advantages over the other. Participants will be monitored for complications such as myocardial infarction and stent thrombosis.

Why it matters

Potential benefit: If successful, this study could improve treatment strategies for patients with complex coronary bifurcation lesions, potentially reducing complications and improving outcomes.

How similar studies have gone: Previous studies have shown comparable outcomes between mini-crush and other stenting techniques, indicating that this approach is not entirely novel but still holds potential for further exploration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged \>18
* PCI with mini-crush or controlled balloon-crush
* Complex coronary bifurcation lesion (Medina 0.1.1 and Medina 1.1.1)

Exclusion Criteria:

* Non-complex bifurcation anatomy
* Bail-out 2-stent (reverse mini-crush or reverse controlled balloon-crush)
* ST-elevation myocardial infarction
* Cardiogenic shock status
* In-stent restenosis
* A history of coronary artery bypass grafting
* Implantation of bare-metal stent
* End-stage hepatic or renal disease
* \<1-year life expectancy

Where it's running

  • Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Algae supplements for heart risk markers and gut health

    This trial will test whether daily supplements of spirulina or Gelidium corneum change gut microbes and improve heart‑disease risk markers in adults over 50 with cardiovascular disease, diabetes, or related conditions.

    Recruiting Universidade do Porto · Porto · NCT07173062

  • Deep phenotyping to explore recovery in young adults after stroke

    This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

    Recruiting The Florey Institute of Neuroscience and Mental Health · Heidelberg, Victoria and 1 other locations · NCT07019493

  • Stem cell therapy for chronic stroke recovery

    This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.

    Recruiting Phase 2 Hokkaido University Hospital · Sapporo, Hokkaido · NCT06752720

  • Optimal antithrombotic strategy for patients with atrial fibrillation undergoing PCI

    This study is testing whether a new blood-thinning treatment for patients with atrial fibrillation undergoing heart procedures is safer and just as effective as the traditional approach that includes more medications.

    Recruiting at 18 sites Phase 4 St. Antonius Hospital · Aalst and 19 other locations · NCT04436978

  • AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

    This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

    Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

  • Web-based therapy using action observation and mirror therapy for arm weakness after stroke

    This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.

    Recruiting Chang Gung Memorial Hospital · Taoyuan · NCT07921108

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.